Rheumatoid arthritis
Diabetes mellitus
Chickenpox
Adenosine deaminase deficiency
The first human gene therapy trial was conducted at the National Institutes of Health in Bethesda, Maryland, in 1990 on a four-year-old girl suffering from ADA deficiency. A functional ADA gene was introduced ex vivo in bone marrow cells of the child through an engineered retrovirus containing a functional ADA gene. The treated cells were reintroduced into the patient’s marrow. So, the correct answer is option D.